Skip to main content Accessibility help
×
Home

Application of multiplex immunoassay technology to investigations of ocular disease

  • Valerie Sloane Jones (a1), Jian Wu (a2), Si-Wei Zhu (a3) and Ruo-Pan Huang (a1) (a3) (a4)

Abstract

Eye-derived fluids, including tears, aqueous humour and vitreous humour often contain molecular signatures of ocular disease states. These signatures can be composed of cytokines, chemokines, growth factors, proteases and soluble receptors. However, the small quantities (<10 µl) of these fluids severely limit the detection of these proteins by traditional enzyme-linked immunosorbent assay or Western blot. To maximise the amount of information generated from the analysis of these specimens, many researchers have employed multiplex immunoassay technologies for profiling the expression or modification of multiple proteins from minute sample volumes.

Copyright

Corresponding author

*Corresponding author: Ruo-Pan Huang, Raybiotech, Inc, 3607 Parkway Lane, Suite 100, Norcross, GA 30092, USA. E-mail: rhuang@raybiotech.com

References

Hide All
1. Broux, B. et al. (2012) CX(3)CR1 drives cytotoxic CD4(+)CD28(−) T cells into the brain of multiple sclerosis patients. Journal of Autoimmunity 38, 10-19
2. Kaplin, A.I. et al. (2005) IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. Journal of Clinical Investigation 115, 2731-2741
3. Ichikawa, T. et al. (2007) Possible impact of salivary influence on cytokine analysis in exhaled breath condensate. Analytical Chemistry Insights 2, 85-92
4. Tatarakis, N. et al. (2014) Clinical, microbiological, and salivary biomarker profiles of dental implant patients with type 2 diabetes. Clinical Oral Implants Research 25, 803-812
5. Kverka, M. et al. (2007) Cytokine profiling in human colostrum and milk by protein array. Clinical Chemistry 53, 955-962
6. Benabid, R. et al. (2012) Neutrophil elastase modulates cytokine expression: contribution to host defense against Pseudomonas aeruginosa-induced pneumonia. Journal of Biological Chemistry 287, 34883-34894
7. Honko, A.N. and Mizel, S.B. (2004) Mucosal administration of flagellin induces innate immunity in the mouse lung. Infection and Immunity 72, 6676-6679
8. Wilson, J.J. et al. (2015) Antibody arrays in biomarker discovery. Advances in Clinical Chemistry 69, 255-324
9. Chowdhury, U.R. et al. (2010) Proteome analysis of human aqueous humor. Investigative Ophthalmology & Visual Science 51, 4921-4931
10. Schwartzman, M.L. et al. (2010) Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy. Diabetes 59, 1780-1788
11. Zhou, L. et al. (2012) In-depth analysis of the human tear proteome. Journal of Proteomics 75, 3877-3885
12. Tiffany, J.M. (2008) The normal tear film. Developments in Ophthalmology 41, 1-20
13. Zhou, L. and Beuerman, R.W. (2012) Tear analysis in ocular surface diseases. Progress in Retinal and Eye Research 31, 527-550
14. Fung, K., Morris, C. and Duncan, M. (2002) Mass spectrometric techniques applied to the analysis of human tears: a focus on the peptide and protein constituents. Advances in Experimental Medicine and Biology 506(Pt A), 601-605
15. Sullivan, D.A., Dartt, D.A. and Meneray, M.A. (2012) Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2: Basic Science and Clinical Relevance, Vol. 438. Springer Science & Business Media, New York, NY
16. Pieragostino, D. et al. (2015) Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases. Proteomics – Clinical Applications 9, 169-186
17. Sack, R.A. et al. (2005) Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents. Investigative Ophthalmology & Visual Science 46, 1228-1238
18. Goren, M.B. (1997) Neural stimulation of lactoferrin and epidermal growth factor secretion by the lacrimal gland. Cornea 16, 501-502
19. Thakur, A., Willcox, M.D. and Stapleton, F. (1998) The proinflammatory cytokines and arachidonic acid metabolites in human overnight tears: homeostatic mechanisms. Journal of Clinical Immunology 18, 61-70
20. Hooper, L.V. et al. (2003) Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nature Immunology 4, 269-273
21. Sack, R.A. et al. (2000) Towards a closed eye model of the pre-ocular tear layer. Progress in Retinal and Eye Research 19, 649-668
22. Sack, R. et al. (2007) Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments. Experimental Eye Research 85, 528-538
23. Mulvenna, I. et al. (2000) Low molecular weight analysis of tears using matrix assisted laser desorption ionization-time of flight mass spectrometry. Clinical & Experimental Ophthalmology 28, 205-207
24. Shoji, J., Inada, N. and Sawa, M. (2006) Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis. Japanese Journal of Ophthalmology 50, 195-204
25. Kokuludag, A. et al. (2001) Serum soluble tumor necrosis factor receptor levels in patients with seasonal allergic rhinitis. Journal of Investigational Allergology & Clinical Immunology 11, 46-48
26. Benson, M. et al. (2000) Increase of the soluble IL-4 receptor (IL-4sR) and positive correlation between IL-4sR and IgE in nasal fluids from school children with allergic rhinitis. Allergy and Asthma Proceedings 21, 89-95
27. Cheung, I.M., McGhee, C.N. and Sherwin, T. (2013) A new perspective on the pathobiology of keratoconus: interplay of stromal wound healing and reactive species-associated processes. Clinical & Experimental Optometry 96, 188-196
28. Kenney, M.C. et al. (2005) Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Investigative Ophthalmology & Visual Science 46, 823-832
29. Pannebaker, C., Chandler, H.L. and Nichols, J.J. (2010) Tear proteomics in keratoconus. Molecular Vision 16, 1949-1957
30. Seppala, H.P. et al. (2006) EMMPRIN and MMP-1 in keratoconus. Cornea 25, 325-330
31. Collier, S.A. (2001) Is the corneal degradation in keratoconus caused by matrix-metalloproteinases? Clinical & Experimental Ophthalmology 29, 340-344
32. Abalain, J.H. et al. (2000) Levels of collagen degradation products (telopeptides) in the tear film of patients with keratoconus. Cornea 19, 474-476
33. Cheung, I.M., McGhee, C. and Sherwin, T. (2014) Deficient repair regulatory response to injury in keratoconic stromal cells. Clinical & Experimental Optometry 97, 234-239
34. Semeraro, F. et al. (2015) Diabetic retinopathy: vascular and inflammatory disease. Journal of Diabetes Research 2015, 582060
35. Maier, R. et al. (2006) Application of multiplex cytometric bead array technology for the measurement of angiogenic factors in the vitreous. Molecular Vision 12, 1143-1147
36. Maier, R. et al. (2008) Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients. Molecular Vision 14, 637-643
37. Nagata, K. et al. (2012) Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis. Investigative Ophthalmology & Visual Science 53, 3827-3833
38. Sato, T. et al. (2009) Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity. Ophthalmology 116, 2165-2169
39. Aiello, L.P. et al. (1998) Diabetic retinopathy. Diabetes Care 21, 143-156
40. Aronson, D. (2008) Hyperglycemia and the pathobiology of diabetic complications. Advances in Cardiology 45, 1-16
41. Kowluru, R.A. (2005) Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxidants & Redox Signaling 7, 1581-1587
42. Kowluru, R.A., Tang, J. and Kern, T.S. (2001) Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50, 1938-1942
43. Capeans, C. et al. (1998) C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. Retina 18, 546-550
44. Elner, S.G. et al. (1995) Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Current Eye Research 14, 1045-1053
45. Hernandez, C. et al. (2005) Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabetic Medicine 22, 719-722
46. Mitamura, Y. et al. (2001) Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy. Ophthalmologica 215, 415-418
47. Canataroglu, H. et al. (2005) Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy. Ocular Immunology and Inflammation 13, 375-381
48. Yuuki, T. et al. (2001) Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. Journal of Diabetes and Its Complications 15, 257-259
49. Aiello, L.P. et al. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine 331, 1480-1487
50. Wang, J. et al. (2014) Vitreous and plasma VEGF levels as predictive factors in the progression of proliferative diabetic retinopathy after vitrectomy. PLoS ONE 9, e110531
51. Banerjee, S. et al. (2007) Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Investigative Ophthalmology & Visual Science 48, 2203-2207
52. Aiello, L.P. et al. (1995) Hypoxic regulation of vascular endothelial growth factor in retinal cells. Archives of Ophthalmology 113, 1538-1544
53. Itakura, H. et al. (2004) Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy. Ophthalmology 111, 1880-1884
54. Murata, T. et al. (1995) Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Research 27, 48-52
55. Reverter, J.L. et al. (2009) Tyrosine phosphorylation of vitreous inflammatory and angiogenic peptides and proteins in diabetic retinopathy. Investigative Ophthalmology & Visual Science 50, 1378-1382
56. Wakefield, D. and Chang, J.H. (2005) Epidemiology of uveitis. International Ophthalmology Clinics 45, 1-13
57. Bodaghi, B. et al. (2012) Toxoplasmosis: new challenges for an old disease. Eye (London) 26, 241-244
58. Gupta, V., Gupta, A. and Rao, N.A. (2007) Intraocular tuberculosis – an update. Survey of Ophthalmology 52, 561-587
59. Hunt, L. and Knott, V. (2016) Serious and common sequelae after Ebola virus infection. The Lancet Infectious Diseases 16, 270-271
60. Varkey, J.B. et al. (2015) Persistence of Ebola virus in ocular fluid during convalescence. The New England Journal of Medicine 372, 2423-2427
61. Perez, V.L. and Caspi, R.R. (2015) Immune mechanisms in inflammatory and degenerative eye disease. Trends in Immunology 36, 354-363
62. Valentincic, N.V. et al. (2011) Intraocular and serum cytokine profiles in patients with intermediate uveitis. Molecular Vision 17, 2003-2010
63. Chen, W. et al. (2015) Cytokine expression profile in aqueous humor and sera of patients with acute anterior uveitis. Current Molecular Medicine 15, 543-549
64. Kalariya, N.M. et al. (2010) Prevention of endotoxin-induced uveitis in rats by plant sterol guggulsterone. Investigative Ophthalmology & Visual Science 51, 5105-5113
65. Takeda, A., Sonoda, K.-H. and Ishibashi, T. (2013) Regulation of Th1 and Th17 cell differentiation in uveitis. Inflammation and Regeneration 33, 261-268
66. Lee, R.W. et al. (2014) Autoimmune and autoinflammatory mechanisms in uveitis. Seminars in Immunopathology 36, 581-594
67. Ooi, K.G. et al. (2006) Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? Clinical Medicine & Research 4, 294-309
68. Curnow, S.J. et al. (2005) Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Investigative Ophthalmology & Visual Science 46, 4251-4259
69. Yoshimura, T. et al. (2009) Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. “Rheumatology (Oxford, England)” 48, 347-354
70. Lahmar, I. et al. (2009) Cytokine profiles in toxoplasmic and viral uveitis. Journal of Infectious Diseases 199, 1239-1249
71. Tezel, G. (2011) The immune response in glaucoma: a perspective on the roles of oxidative stress. Experimental Eye Research 93, 178-186
72. Tezel, G. and A.P.O.R.I.C.W.G. Fourth (2009) The role of glia, mitochondria, and the immune system in glaucoma. Investigative Ophthalmology & Visual Science 50, 1001-1012
73. Kuchtey, J. et al. (2010) Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor. Investigative Ophthalmology & Visual Science 51, 6441-6447
74. Thirumangalakudi, L. et al. (2007) IL-8 induces expression of matrix metalloproteinases, cell cycle and pro-apoptotic proteins, and cell death in cultured neurons. Journal of Alzheimer's Disease 11, 305-311
75. Birke, M.T. et al. (2010) Changes of osteopontin in the aqueous humor of the DBA2/J glaucoma model correlated with optic nerve and RGC degenerations. Investigative Ophthalmology & Visual Science 51, 5759-5767
76. Chang, B. et al. (1999) Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nature Genetics 21, 405-409
77. Neumann, C. et al. (2014) Osteopontin is induced by TGF-beta2 and regulates metabolic cell activity in cultured human optic nerve head astrocytes. PLoS ONE 9, e92762
78. Del Rio, P. et al. (2011) GDNF-induced osteopontin from Muller glial cells promotes photoreceptor survival in the Pde6brd1 mouse model of retinal degeneration. Glia 59, 821-832
79. Cha, D.M. et al. (2013) Comparative analysis of aqueous humor cytokine levels between patients with exudative age-related macular degeneration and normal controls. Investigative Ophthalmology & Visual Science 54, 7038-7044
80. Spraul, C.W. et al. (2002) Octreotide inhibits growth factor-induced bovine choriocapillary endothelial cells in vitro. Graefe's Archive for Clinical and Experimental Ophthalmology 240, 227-231
81. Cheung, C.M. et al. (2012) Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy. Molecular Vision 18, 830-837
82. Altshuler, D., Daly, M.J. and Lander, E.S. (2008) Genetic mapping in human disease. Science 322, 881-888
83. Mizuki, N. et al. (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nature Genetics 42, 703-706
84. Remmers, E.F. et al. (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nature Genetics 42, 698-702
85. Kirino, Y. et al. (2013) Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1. Nature Genetics 45, 202-207
86. Xavier, J.M. et al. (2012) Association study of IL10 and IL23R-IL12RB2 in Iranian patients with Behcet's disease. Arthritis and Rheumatism 64, 2761-2772
87. Abraham, C. and Cho, J. (2009) Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflammatory Bowel Diseases 15, 1090-1100
88. Di Cesare, A., Di Meglio, P. and Nestle, F.O. (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. Journal of Investigative Dermatology 129, 1339-1350
89. Merida, S. et al. (2015) New immunosuppressive therapies in uveitis treatment. International Journal Molecular Science 16, 18778-18795
90. Klein, R.J. et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389
91. Edwards, A.O. et al. (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308, 421-424
92. Haines, J.L. et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419-421
93. Rivera, A. et al. (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Human Molecular Genetics 14, 3227-3236
94. Dewan, A. et al. (2006) HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314, 989-992
95. Tong, Y. et al. (2010) LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: a HuGE review and meta-analysis. Molecular Vision 16, 1958-1981
96. Fritsche, L.G. et al. (2013) Seven new loci associated with age-related macular degeneration. Nature Genetics 45, 433-439, 439e1-2
97. Arakawa, S. et al. (2011) Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nature Genetics 43, 1001-1004
98. Nakano, M. et al. (2009) Three susceptible loci associated with primary open-angle glaucoma identified by genome-wide association study in a Japanese population. Proceedings of the National Academy of Sciences of the United States of America 106, 12838-12842
99. Rao, K.N., Kaur, I. and Chakrabarti, S. (2009) Lack of association of three primary open-angle glaucoma-susceptible loci with primary glaucomas in an Indian population. Proceedings of the National Academy of Sciences of the United States of America 106, E125-E126; author reply E127
100. Thorleifsson, G. et al. (2010) Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nature Genetics 42, 906-909
101. Burdon, K.P. et al. (2011) Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nature Genetics 43, 574-578
102. Baratz, K.H. et al. (2010) E2-2 protein and Fuchs's corneal dystrophy. New England Journal of Medicine 363, 1016-1024
103. Li, Y.J. et al. (2011) Replication of TCF4 through association and linkage studies in late-onset fuchs endothelial corneal dystrophy. PLoS ONE 6, e18044
104. Thalamuthu, A. et al. (2011) Association of TCF4 gene polymorphisms with Fuchs’ corneal dystrophy in the Chinese. Investigative Ophthalmology & Visual Science 52, 5573-5578
105. Li, X.H. et al. (2012) A genome-wide association study identifies a potential novel gene locus for keratoconus, one of the commonest causes for corneal transplantation in developed countries. Human Molecular Genetics 21, 421-429
106. Burdon, K.P. et al. (2011) Association of polymorphisms in the hepatocyte growth factor gene promoter with keratoconus. Investigative Ophthalmology & Visual Science 52, 8514-8519
107. Gu, J. et al. (2009) Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Molecular & Cellular Proteomics 8, 1338-1349
108. Nguyen, T.T. et al. (2009) Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy the multi-ethnic study of atherosclerosis. Diabetes Care 32, 1704-1709
109. Hirano, T. et al. (2012) A case of Behcet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab. Modern Rheumatology 22, 298-302
110. Adan, A. et al. (2013) Tocilizumab treatment for refractory uveitis-related cystoid macular edema. Graefe's Archive for Clinical and Experimental Ophthalmology 251, 2627-2632
111. Sfikakis, P.P. et al. (2004) Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behcet disease. Annals of Internal Medicine 140, 404-406
112. Bravo-Ljubetic, L. et al. (2013) Adalimumab therapy for refractory childhood uveitis. Journal of AAPOS 17, 456-459
113. Simonini, G. et al. (2013) Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. Pediatric Rheumatology Online Journal 11, 16
114. Gul, A. et al. (2012) Interleukin-1beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Annals of the Rheumatic Diseases 71, 563-566
115. Ferrara, N., Gerber, H.P. and LeCouter, J. (2003) The biology of VEGF and its receptors. Nature Medicine 9, 669-676
116. Hellström, A. et al. (2002) IGF-I is critical for normal vascularization of the human retina. The Journal of Clinical Endocrinology & Metabolism 87, 3413-3416
117. Jacobo, S.M. and Kazlauskas, A. (2015) Insulin-like growth factor 1 (IGF-1) stabilizes nascent blood vessels. Journal of Biological Chemistry 290, 6349-6360
118. Rajappa, M., Saxena, P. and Kaur, J. (2010) Ocular angiogenesis: mechanisms and recent advances in therapy. Advances in Clinical Chemistry 50, 103-121
119. Sene, A., Chin-Yee, D. and Apte, R.S. (2015) Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye. Trends in Molecular Medicine 21, 43-51
120. Doukas, J. et al. (2008) Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema. Journal of Cellular Physiology 216, 29-37
121. Dalal, M. et al. (2013) Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology 251, 2705-2709
122. Kaiser, P.K. (2013) Emerging therapies for neovascular age-related macular degeneration: drugs in the pipeline. Ophthalmology 120(5 Suppl), S11-S15
123. Prendes, M.A. et al. (2013) The role of transforming growth factor β in glaucoma and the therapeutic implications. British Journal of Ophthalmology 97, 680-686
124. Wordinger, R.J., Sharma, T. and Clark, A.F. (2014) The role of TGF-β2 and bone morphogenetic proteins in the trabecular meshwork and glaucoma. Journal of Ocular Pharmacology and Therapeutics 30, 154-162
125. Barabasi, A.-L. and Oltvai, Z.N. (2004) Network biology: understanding the cell's functional organization. Nature Reviews Genetics 5, 101-113
126. Copeland, S., Siddiqui, J. and Remick, D. (2004) Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokines. Journal of Immunological Methods 284, 99-106
127. Ingvarsson, J. et al. (2006) One-step fractionation of complex proteomes enables detection of low abundant analytes using antibody-based microarrays. Journal of Proteome Research 5, 170-176
128. Chang, L. et al. (2012) Single molecule enzyme-linked immunosorbent assays: theoretical considerations. Journal of Immunological Methods 378, 102-115
129. Rissin, D.M. et al. (2010) Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nature Biotechnology 28, 595-599
130. Fischer, S.K. et al. (2015) Emerging technologies to increase ligand binding assay sensitivity. The AAPS Journal 17, 93-101
131. Rissin, D.M. et al. (2013) Multiplexed single molecule immunoassays. Lab on a Chip 13, 2902-2911

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed